🇺🇸 FDA
Pipeline program

Trichostatin A

VP-VTR-297-2201

Phase 2 small_molecule active

Quick answer

Trichostatin A for Onychomycosis of Toenail is a Phase 2 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Vanda Pharmaceuticals
Indication
Onychomycosis of Toenail
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials